NCT04179695Recruiting
Evaluation of a New Communication Aid Tool to Favor Global Patient Centered Care
Optimizing PD Patient's Health Pathways: Favoring Global, Patient Centered Care by a New Communication Aid Tool PARKINSUN
Source: ClinicalTrials.gov · Last updated 23 Dec 2025
Brief summary (registry, in English)
PARKINSUN is a new communication aid tool, expected to favor global patient centered care for PD patients during consultation with GPs and neurologists. Two groups of patients will be randomized to use or not PARKINSUN when they consult their physicians every 3 months during 7 months.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 25 Nov 2019
- Start date
- 21 Jul 2020
- Primary completion date
- Dec 2026
- Lead sponsor
- University Hospital, Lille
- Diseases
- Parkinson disease
- NCT number
- NCT04179695
What you commit to
- Study type: Interventional
- Planned participants: 120
- From 21 Jul 2020 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Administrative reasons: impossibility of receiving informed information, inability to participate in the whole study, absence of coverage by the social security system, refusal to sign consent.
Other
- Subject under tutelage or curtailer.
- Subject not fluent in the French language to understand the instructions necessary to carry out the cognitive tests.
Who the study is looking for
- Adult men and women with all stages of PD
- Without severe chronic neurological or mental or psychiatric pathology
- Absence of cognitive impairment affecting autonomy (MDS criteria of dementia and MOCA \> 22)
- able to come (alone or accompanied) to consultation
- Affiliate or beneficiary of a social security scheme
- Subject having signed informed consent
- Patient willing to comply with all procedures of the study and its duration
Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hopital Roger Salengro, CHU Lille Coordinator of this site? Confirm its status | Lille | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.